| Financial Year |
March 31 2023 |
| Monetary Funds |
1,919,033,344.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
31,013,131.43 |
| Accounts Receivable |
2,600,333,408.29 |
| Advances to Suppliers |
185,365,977.56 |
| Other Receivables |
47,965,303.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,099,685,104.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,600,000.00 |
| Other Current Assets |
1,160,327,772.41 |
| Total Current Assets |
11,206,258,639.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
72,677,811.40 |
| Long-term Equity Investment |
294,807,597.60 |
| Investment Properties |
-- |
| Fixed Assetes |
3,788,742,222.93 |
| Under-construction Projects |
676,389,700.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
919,124,473.47 |
| R&D expenses |
240,335,268.36 |
| Goodwill |
1,677,425,000.21 |
| Long-Term Deferred and Prepaid Expenses |
524,918,080.72 |
| Deferred Income Tax Assets |
1,565,551,206.27 |
| Other Non-Current Assets |
342,003,074.65 |
| Sub-Total of Non-Current Assets |
10,249,558,698.14 |
| Total Assets |
21,455,817,338.11 |
| Short-Term Loans |
5,678,477,363.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,543,870,009.22 |
| Accounts Payable |
2,266,278,413.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
170,738,441.83 |
| Taxes Payable |
24,054,044.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,357,900,328.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,396,618,537.26 |
| Other Current Liabilities |
72,483,393.07 |
| Sub-Total of Current Liabilities |
12,605,187,946.97 |
| Long-term Loans |
1,461,783,329.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
946,564,484.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,663,729.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,762,587,912.15 |
| Total Liabilities |
15,367,775,859.12 |
| Paid-In Capital(Or Share Stock) |
3,116,416,220.00 |
| Capital Surplus |
4,457,015,262.14 |
| Surplus Reserve |
377,000,773.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,927,877,993.47 |
| Minority Stockholder's Interest |
1,042,079,374.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,045,962,104.00 |
| Owner's Equity（Stockholder's Equity） |
6,088,041,478.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,455,817,338.11 |
